Page 97 - Read Online

Castro et al. Mini-invasive Surg 2020;4:47 I http://dx.doi.org/10.20517/2574-1225.2020.14 Page 11 of 13

Consent for publication
Not applicable.

Copyright
© The Author(s) 2020.

REFERENCES
1. World Health Organization. Obesity and overweight. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-
overweight. [Last accessed on 29 Jul 2020]
2. Guerron AD, Ortega CB, Lee HJ, Davalos G, Ingram J, et al. Asthma medication usage is significantly reduced following bariatric
surgery. Surg Endosc 2019;33:1967-75.
3. ASMBS. Estimate of Bariatric Surgery Numbers, 2011-2018. Available from: https://asmbs.org/resources/estimate-of-bariatric-surgery-
numbers#. [Last accessed on 29 Jul 2020]
4. Angrisani L, Santonicola A, Iovino P, Vitiello A, Higa K, et al. IFSO worldwide survey 2016: primary, endoluminal, and revisional
procedures. Obes Surg 2018;28:3783-94.
5. Fernández-Soto ML, Martín-Leyva A, González-Jiménez A, García-Rubio J, Cózar-Ibáñez A, et al. Remission of type 2 diabetes mellitus
after bariatric surgery - comparison between procedures. Endokrynol Pol 2017;68:18-25.
6. Singh AK, Singh R, Kota SK. Bariatric surgery and diabetes remission: Who would have thought it? Indian J Endocrinol Metab
2015;19:563-76.
7. Ryou M, Ryan MB, Thompson CC. Current status of endoluminal bariatric procedures for primary and revision indications. Gastrointest
Endosc Clin N Am 2011;21:315-33.
8. Gollisch KSC, Raddatz D. Endoscopic intragastric balloon: a gimmick or a viable option for obesity? Ann Transl Med 2020;8:S8.
9. Papademetriou M, Popov V. Intragastric balloons in clinical practice. Gastrointest Endosc Clin N Am 2017;27:245-56.
10. Ashrafian H, Monnich M, Braby TS, Smellie J, Bonanomi G, et al. Intragastric balloon outcomes in super-obesity: a 16-year city center
hospital series. Surg Obes Relat Dis 2018;14:1691-9.
11. Moore RL, Seger MV, Garber SM, Smith AB, Nguyen RT, et al. Clinical safety and effectiveness of a swallowable gas-filled intragastric
balloon system for weight loss: consecutively treated patients in the initial year of U.S. commercialization. Surg Obes Relat Dis
2019;15:417-23.
12. Yorke E, Switzer NJ, Reso A, Shi X, de Gara C, et al. Intragastric balloon for management of severe obesity: a systematic review. Obes
Surg 2016;26:2248-54.
13. Sullivan S. Aspiration therapy for obesity. Gastrointest Endosc Clin N Am 2017;27:277-88.
14. Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic bariatric and metabolic therapies: new and emerging technologies.
Gastroenterology 2017;152:1791-801.
15. Sullivan S, Stein R, Jonnalagadda S, Mullady D, Edmundowicz S. Aspiration therapy leads to weight loss in obese subjects: a pilot study.
Gastroenterology 2013;145:1245-52.e1-5.
16. Thompson CC, Abu Dayyeh BK, Kushner R, Sullivan S, Schorr AB, et al. Percutaneous gastrostomy device for the treatment of Class II
and Class III obesity: results of a randomized controlled trial. Am J Gastroenterol 2017;112:447-57.
17. Nyström M, Machytka E, Norén E, Testoni PA, Janssen I, et al. Aspiration therapy as a tool to treat obesity: 1- to 4-year results in a
201-Patient Multi-Center Post-Market European Registry Study. Obes Surg 2018;28:1860-8.
18. Goyal D, Watson RR. Endoscopic bariatric therapies. Curr Gastroenterol Rep 2016;18:26.
19. Abu Dayyeh BK, Edmundowicz SA, Jonnalagadda S, Kumar N, Larsen M, et al. ASGE Bariatric Endoscopy Task Force; ASGE
Technology Committee, Endoscopic bariatric therapies. Gastrointest Endosc 2015;81:1073-86.
20. Rodriguez-Grunert L, Galvao Neto MP, Alamo M, Ramos AC, Baez PB, et al. First human experience with endoscopically delivered and
retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis 2008;4:55-9.
21. Escalona A, Pimentel F, Sharp A, Becerra P, Slako M, et al. Weight loss and metabolic improvement in morbidly obese subjects implanted
for 1 year with an endoscopic duodenal-jejunal bypass liner. Ann Surg 2012;255:1080-5.
22. Sandler BJ, Rumbaut R, Swain CP, Torres G, Morales L, et al. One-year human experience with a novel endoluminal, endoscopic gastric
bypass sleeve for morbid obesity. Surg Endosc 2015;29:3298-303.
23. Marinos G, Eliades C, Muthusamy R, Iki K, Kline C, et al. First clinical experience with the transpyloric shuttle (TPS(R)) device, a
non-surgical endoscopic treatment for obesity: results from a 3-month and 6-month study: Abstract 2013. Available from: https://www.
sages.org/meetings/annual-meeting/abstracts-archive/first-clinical-experience-with-the-transpyloric-shuttle-tpsr-device-a-non-surgical-
endoscopic-treatment-for-obesity-results-from-a-3-month-and-6-month-study/. [Last accessed on 3 Aug 2020]
24. Giuliani A, Romano L, Marchese M, Necozione S, Cianca G, et al. Gastric leak after laparoscopic sleeve gastrectomy: management with
endoscopic double pigtail drainage. A systematic review. Surg Obes Relat Dis 2019;15:1414-9.
25. Diaz R, Davalos G, Welsh LK, Portenier D, Guerron AD. Use of magnets in gastrointestinal surgery. Surg Endosc 2019;33:1721-30.
26. Ryou M, Aihara H, Thompson CC. Minimally invasive entero-enteral dual-path bypass using self-assembling magnets. Surg Endosc
2016;30:4533-8.
27. Machytka E, Bužga M, Zonca P, Lautz DB, Ryou M, et al. Partial jejunal diversion using an incisionless magnetic anastomosis system: